Exploring the Antitumor Efficacy of N-Heterocyclic Nitrilotriacetate Oxidovanadium(IV) Salts on Prostate and Breast Cancer Cells.
Humans
Antineoplastic Agents
/ pharmacology
Breast Neoplasms
/ drug therapy
Male
Female
MCF-7 Cells
Prostatic Neoplasms
/ drug therapy
Nitrilotriacetic Acid
/ chemistry
Structure-Activity Relationship
Cell Line, Tumor
Cell Proliferation
/ drug effects
Heterocyclic Compounds
/ chemistry
Vanadium
/ chemistry
PC-3 Cells
Cell Cycle
/ drug effects
Molecular Structure
Salts
/ chemistry
Cell Survival
/ drug effects
Apoptosis
/ drug effects
antitumor activity
breast cancer cells
crystal structure
prostate cancer cells
vanadium complexes
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
19 Jun 2024
19 Jun 2024
Historique:
received:
10
05
2024
revised:
05
06
2024
accepted:
17
06
2024
medline:
27
6
2024
pubmed:
27
6
2024
entrez:
27
6
2024
Statut:
epublish
Résumé
The crystal structures of two newly synthesized nitrilotriacetate oxidovanadium(IV) salts, namely [QH][VO(nta)(H
Identifiants
pubmed: 38930989
pii: molecules29122924
doi: 10.3390/molecules29122924
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Nitrilotriacetic Acid
KA90006V9D
Heterocyclic Compounds
0
Vanadium
00J9J9XKDE
Salts
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : University of Gdansk, Poland
ID : 539 - T090 - B111 - 24
Organisme : Gdansk University of Technology, Poland
ID : DEC-2/2021/IDUB/V.6/Si
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.